Watertown, MA – (November 12th, 2025) – NanoDx, Inc. is a medical device startup focused on developing point-of-care diagnostic solutions designed to help people live healthier, safer, happier lives. NanoDx’s first product focus is for simple, fast, and cost-efficient assessment of Traumatic Brain Injury. The company recently announced the grand opening of its new office and expanded laboratory space in Watertown, MA. The new facility marks a major milestone in the company’s growth and its commitment to advancing fast, accurate point of care diagnostics. The ribbon-cutting ceremony, held on Monday, October 20th, brought together company leadership, investors, members of the Watertown community and distinguished guests.
A New Chapter of Growth and Innovation
The expanded space features over 20,000 SF of state-of-the-art laboratories and collaborative office areas that will enable NanoDx™ to scale its research, development, and commercialization efforts for its groundbreaking technology.
George Serafin, CEO of NanoDx, Inc. said:
“The opening of this laboratory starts a new chapter in NanoDx’s journey developing cutting edge, in vitro diagnostic point-of-care / point-of-injury solutions. This brand new, purpose-built laboratory facility, located in the greater Boston biotech hub, will empower our R&D team to accelerate innovation, expand our scientific capabilities, and build a foundation for us to fulfill our mission to help people worldwide live healthier, safer, and happier lives.”
Part of Watertown’s Expanding Life Sciences Hub
Located at 66 Galen Street, NanoDx™ joins a growing network of innovative life science companies investing in Watertown, an area that has become a hub for cutting edge biomedical research.
George Proakis, Watertown City Manager, said:
“Watertown is thrilled to welcome NanoDx™ to Watertown as the latest business to join the city’s burgeoning medical technology landscape. The NanoDx team and their cutting-edge medical technology are a perfect match with our 66 Galen lab location, where they will be consolidating their national operations to experience their many future successes all here in Watertown.”
Massachusetts Life Sciences Community Continues to Thrive
NanoDx’s expansion underscores Massachusetts’ leadership in biotechnology and medical technology innovation — driven by collaboration between startups, research institutions, and public-private partnerships. Massachusetts is a leading life science hub due to its concentration of life science companies, academic institutions, and research institutions. This ecosystem allows us to fuel innovation, ensuring future growth and positive outcomes for patients.
Ben Bradford, Head of External Affairs at MassBio, said:
“It’s always exciting to see innovative companies like NanoDx™ planting deeper roots here in Massachusetts. Their new space in Watertown will support the creative drive, breakthrough technology, and dedication to patients that define our life sciences ecosystem.”
As a member of MassMEDIC, the state’s leading medical-device trading association, NanoDx’s new facility represents another important investment in the Commonwealth’s MedTech infrastructure.
Brain Johnson, President of MassMEDIC said:
“Massachusetts’ lead in medical technology is built on the kind of innovations being brought to market by companies like NanoDx™. We are thrilled to see NanoDx™ expand its operations in Watertown and continue its commitment to the Commonwealth.”
Supporting the Military and Advancing Brain Health
One of NanoDx’s focus areas is the Department of Defense and U.S. service members. NanoDx™ has developed a strong Military Advisory Board that plays a critical role in shaping our go-to-market strategy for the Department of Defense. The board member’s strategic insights ensure that NanoDx’s technology is developed and deployed in ways that align with the operational needs, medical priorities, and readiness goals of the U.S. Armed Forces.
Jack Hammond, Brigadier General U.S. Army (Ret.), MILAB Chairman & Executive Director of Home Base said:
“Fast, accurate point-of-care detection of traumatic brain injury is a game-changer for our military. Early diagnosis ensures Soldiers get the right treatment when they need it and helps to reduce the chance of reinjury before the brain has healed. This technology replaces subjective field assessments with clinical certainty—bringing science, safety, and accountability to the battlefield.”
About NanoDx™
NanoDx™ is a privately held medical device company developing breakthrough point-of-care diagnostic solutions that deliver lab-quality results in minutes using a patented nano-biosensor platform. The NanoDx™ System, the company’s first commercial platform, enables rapid, accurate measurement of biomarkers at the patient’s side – enabling faster clinical decisions, greater operational efficiency, and wider access to diagnostics.
NanoDx’s mission is to revolutionize healthcare by leveraging our nano biosensor platform technology develop innovative, cost-effective diagnostic solutions designed to help people worldwide live healthier, safer, and happier lives. We strive to be a global leader in point-of-care diagnostics, empowering healthcare professionals, advancing clinical research and innovation, promoting health and wellness, expanding patient access, and reducing the cost of healthcare.
Learn more at www.nanodiagnostics.com